Beta Bionics Inc.
BBNX | NASDAQ
$16.55
-$0.20 (-1.19%)
Nov 2, 2026, 10:26 AM ET · Market open
TTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 127.27M | 119.01M | 110.24M | 100.25M | 88.57M | 78.02M | 69.83M | 65.12M | 53.03M | 39.42M | 24.38M | 11.44M | 3.09M |
Cost of Revenue | 52.65M | 49.61M | 47.24M | 44.71M | 40.29M | 35.95M | 32.17M | 29.24M | 23.77M | 17.85M | 10.89M | 5.16M | 1.87M |
Gross Profit | 74.61M | 69.4M | 63M | 55.54M | 48.28M | 42.08M | 37.66M | 35.89M | 29.26M | 21.57M | 13.49M | 6.29M | 1.23M |
Operating Income | -92.58M | -83.02M | -77.31M | -71.68M | -68.59M | -62.53M | -54.44M | -45.25M | -40.58M | -38.39M | -26.6M | -17.15M | -8.78M |
Interest Income | 9.47M | 10.04M | 10.87M | 10.93M | 9.23M | 7.22M | 5.21M | 3.91M | 4.21M | 3.78M | 2.78M | 1.64M | 393K |
Pretax Income | -83.12M | -72.97M | -66.44M | -73.2M | -77.84M | -73.37M | -70.96M | -54.76M | -55.5M | -54.44M | -39.98M | -27.53M | -8.68M |
Net Income | -83.12M | -72.97M | -66.44M | -73.2M | -77.84M | -73.37M | -70.96M | -54.76M | -55.5M | -54.44M | -39.98M | -27.53M | -8.68M |
Selling & General & Admin | 124.49M | 113.5M | 102.76M | 92.43M | 83M | 73.79M | 63.8M | 54.96M | 48.41M | 39.82M | 26.3M | 15.12M | 6.15M |
Research & Development | 42.7M | 38.92M | 37.56M | 34.79M | 33.87M | 30.82M | 28.3M | 26.18M | 21.43M | 20.14M | 13.79M | 8.31M | 3.85M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 167.2M | 152.42M | 140.31M | 127.22M | 116.88M | 104.61M | 92.1M | 81.14M | 69.84M | 59.96M | 40.09M | 23.44M | 10.01M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 86.83M | 77.75M | 68.74M | 61.4M | 55.87M | 49.47M | 42.83M | 37.09M | 31.9M | 25.58M | 16.61M | 8.95M | 3.33M |
Cost & Expenses | 219.85M | 202.03M | 187.55M | 171.93M | 157.16M | 140.55M | 124.27M | 110.38M | 93.62M | 77.81M | 50.98M | 28.59M | 11.88M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 46.54M | 44.55M | 44.44M | 40.53M | 43.63M | 43.39M | 43.12M | 42.86M | 42.86M | 42.86M | 43.35M | 42.86M | 42.86M |
Shares Outstanding (Diluted) | 46.54M | 44.55M | 44.44M | 40.53M | 43.63M | 43.39M | 43.12M | 42.86M | 42.86M | 42.86M | 43.35M | 42.86M | 42.86M |
EPS (Basic) | -1.87 | -1.68 | -1.54 | -1.71 | -1.80 | -1.70 | -1.65 | -1.28 | -1.30 | -1.27 | -0.93 | -0.64 | -0.20 |
EPS (Diluted) | -1.87 | -1.68 | -1.54 | -1.71 | -1.80 | -1.70 | -1.65 | -1.28 | -1.30 | -1.27 | -0.93 | -0.64 | -0.20 |
EBITDA | -84.51M | -71.42M | -63.18M | -70.32M | -75.37M | -70.97M | -68.64M | -52.47M | -53.2M | -52.45M | -38.56M | -26.67M | -8.37M |
EBIT | -87.55M | -75.15M | -66.44M | -73.2M | -77.84M | -73.37M | -70.96M | -54.76M | -55.5M | -54.44M | -39.98M | -27.53M | -8.68M |
Depreciation & Amortization | 4.35M | 3.72M | 3.26M | 2.88M | 2.47M | 2.4M | 2.32M | 2.28M | 2.3M | 1.99M | 1.42M | 855.33K | 311.33K |
Add to Watchlist
Select watchlists to add or remove BBNX